Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

BACKGROUND: The colony stimulating factor 1 receptor (CSF1R) ligands, CSF1 and interleukin-34, and the KIT ligand, stem cell factor, are expressed in glioblastoma (GB). Microglia, macrophages, blood vessels, and tumor cells also express CSF1R, and depletion of the microglia reduces tumor burden and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Butowski, Nicholas, Colman, Howard, De Groot, John F., Omuro, Antonio M., Nayak, Lakshmi, Wen, Patrick Y., Cloughesy, Timothy F., Marimuthu, Adhirai, Haidar, Sam, Perry, Arie, Huse, Jason, Phillips, Joanna, West, Brian L., Nolop, Keith B., Hsu, Henry H., Ligon, Keith L., Molinaro, Annette M., Prados, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4799682/
https://ncbi.nlm.nih.gov/pubmed/26449250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados